Related Experiment Videos
Dual immunomodulation by met-enkephalin
1Department of Microbiology, School of Medicine, University of New Mexico, Albuquerque 87131.
Abstract:
Met-enkephalin (MENK) is an opioid peptide that is released during physiological stress and is reported to either up-regulate or down-regulate the immune response. Our previous experiments showed the ability of 10(-7) M MENK to modulate the plaque-forming cell (PFC) response of Mishell-Dutton cultures treated with low, optimal, and large concentrations of sheep erythrocyte (SE) antigen. In the present series of experiments the PFC response was measured in splenocyte cultures challenged with incremental concentrations of SE in the presence of 10(-7) M MENK. These experiments illustrate what we consider to be true modulation, i.e., the ability of MENK to modulate immune function only during the presence of a strong immune signal. When the immune signal was strong, as represented by a strong PFC response, MENK suppressed the PFC response. Conversely, when the strongest immune signal was high-antigen suppression of the PFC response, MENK overcame the suppression and frequently returned the PFC response to a greater than optimal level. In a true modulatory fashion MENK had no effect in those regions of the dose-response curve where there was insufficient antigen to induce a strong immune signal.
Insights
Met-enkephalin (MENK) true immune modulation occurs only with strong immune signals. MENK suppressed strong responses but overcame high-antigen suppression, demonstrating context-dependent immune regulation.
Area of Science:
- Immunology
- Neuroendocrinology
- Peptide Signaling
Background:
- Met-enkephalin (MENK), an opioid peptide, influences immune responses during stress.
- Previous studies indicated MENK's ability to modulate the plaque-forming cell (PFC) response.
- The exact conditions for MENK's immunomodulatory effects remained unclear.
Purpose of the Study:
- To investigate the precise conditions under which MENK modulates immune function.
- To determine if MENK's effects are dose-dependent on the immune signal strength.
- To characterize MENK's role in regulating the plaque-forming cell (PFC) response.
Main Methods:
- Utilized Mishell-Dutton cultures with splenocytes.
- Challenged cultures with incremental concentrations of sheep erythrocyte (SE) antigen.
- Assessed the plaque-forming cell (PFC) response in the presence of 10(-7) M MENK.
Main Results:
- MENK demonstrated true immunomodulation, acting only during strong immune signals.
- MENK suppressed the PFC response when the immune signal was strong.
- MENK overcame high-antigen-induced suppression, enhancing the PFC response above optimal levels.
- MENK had no significant effect when the immune signal was weak (insufficient antigen).
Conclusions:
- MENK's immunomodulatory capacity is contingent on the strength of the immune stimulus.
- MENK exhibits context-dependent regulation, suppressing strong responses and boosting suppressed ones.
- These findings clarify the specific conditions for MENK's role in immune function.